Literature DB >> 18815440

Hippocampal estrogen receptor-alpha splice variant TADDI in the human brain in aging and Alzheimer's disease.

T A Ishunina1, D F Swaab.   

Abstract

BACKGROUND/AIMS: Estrogen receptor-alpha (ER alpha) splice variants are important for understanding estrogen effects on the brain and estrogen therapy pitfalls. We addressed the question whether a novel ER alpha splice variant TADDI is expressed at the protein level in the human brain and whether it changes in relation to aging and Alzheimer's disease (AD).
METHODS: Immunoreactivity (-ir) for TADDI was assessed on postmortem human brain material from a total of 116 cases.
RESULTS: The highest levels of this splice form were found in the hypothalamic supraoptic nucleus (SON), pontine nuclei, medulla oblongata, gray matter of the spinal cord, the hippocampus, glomeruli of the cerebellum, the nucleus basalis of Meynert (NBM), and the tuberomamillary nucleus (TMN). TADDI-ir was mainly confined to the cytoplasm but was also determined in the nuclei of hippocampal neurons from young patients. In the hippocampus, the NBM, and the TMN, TADDI-ir was higher in postmenopausal women than in women <or=50 years old. In these brain areas and in the SON, it was diminished in AD women. In the NBM of AD men, TADDI-ir was enhanced.
CONCLUSION: Aging- and AD-related changes in TADDI-ir show that it should be considered for the sensitivity of the neural tissue to estrogen therapy. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815440     DOI: 10.1159/000158573

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  12 in total

1.  Regulation of transcriptional activation function of rat estrogen receptor α (ERα) by novel C-terminal splice inserts.

Authors:  Pallob Kundu; Min Li; Rong Lu; Enrico Stefani; Ligia Toro
Journal:  Mol Cell Endocrinol       Date:  2014-11-07       Impact factor: 4.102

2.  Steroid receptor coactivator-2 expression in brain and physical associations with steroid receptors.

Authors:  M A Yore; D Im; L K Webb; Y Zhao; J G Chadwick; H A Molenda-Figueira; S J Haidacher; L Denner; M J Tetel
Journal:  Neuroscience       Date:  2010-06-02       Impact factor: 3.590

3.  Membrane-initiated estradiol signaling in immortalized hypothalamic N-38 neurons.

Authors:  Reymundo Dominguez; Phoebe Dewing; John Kuo; Paul Micevych
Journal:  Steroids       Date:  2013-01-05       Impact factor: 2.668

4.  Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy.

Authors:  Victor W Henderson; Roberta Diaz Brinton
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 5.  Nuclear receptor coactivators: regulators of steroid action in brain and behaviour.

Authors:  M J Tetel; K D Acharya
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

Review 6.  Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging.

Authors:  Thomas C Foster
Journal:  Hippocampus       Date:  2011-04-27       Impact factor: 3.899

Review 7.  Estrogen-induced plasticity from cells to circuits: predictions for cognitive function.

Authors:  Roberta Diaz Brinton
Journal:  Trends Pharmacol Sci       Date:  2009-03-18       Impact factor: 14.819

8.  Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease.

Authors:  Natalie A Twine; Karolina Janitz; Marc R Wilkins; Michal Janitz
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

9.  Comparison of the Antidepressant-Like Effects of Estradiol and That of Selective Serotonin Reuptake Inhibitors in Middle-Aged Ovariectomized Rats.

Authors:  Saloua Benmansour; Luis D Arroyo; Alan Frazer
Journal:  Front Aging Neurosci       Date:  2016-12-21       Impact factor: 5.750

10.  Estrogen signaling and the aging brain: context-dependent considerations for postmenopausal hormone therapy.

Authors:  Natasha N Mott; Toni R Pak
Journal:  ISRN Endocrinol       Date:  2013-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.